作者: Ehsanollah Esfandiari , Iain B. McInnes , George Lindop , Fang-Ping Huang , Max Field
DOI: 10.4049/JIMMUNOL.167.9.5338
关键词:
摘要: Serum from patients with systemic lupus erythematosus (SLE) contained significantly higher concentrations of IL-18 than normal individuals. MRL/lpr mice, which develop spontaneous lupus-like autoimmune disease, also had serum levels wild-type MRL/++ mice. Daily injections or plus IL-12 resulted in accelerated proteinuria, glomerulonephritis, vasculitis, and raised proinflammatory cytokines IL-18-treated mice developed a "butterfly" facial rash resembling clinical SLE. In contrast, treated did not rash. The lesion the showed epidermal thickening intense chronic inflammation accompanied by increased apoptosis, Ig deposition, early Th2 response compared control These data therefore show that is an important mediator disease may thus be novel target for therapeutic intervention diseases.